|
|
Blood, 15 July 2005, Vol. 106, No. 2, pp. 550-557.
Prepublished online as a Blood First Edition Paper on April 5, 2005; DOI 10.1182/blood-2004-12-4866.
Previous Article | Next Article 
Submitted December 22, 2004
Accepted March 30, 2005
Molecular mechanism and functional implications of thrombin-mediated tyrosine phosphorylation of PKC in platelets
Swaminathan Murugappan, Haripriya Shankar, Surya Bhamidipati, Robert T Dorsam, Jianguo Jin, and Satya P Kunapuli*
Department of Physiology, Temple University School of Medicine, Philadelphia, PA, USA; Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA, USA
Department of Physiology, Temple University School of Medicine, Philadelphia, PA, USA
Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA; Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA, USA
Department of Physiology, Temple University School of Medicine, Philadelphia, PA, USA; Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA; Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA, USA
* Corresponding author; email: spk{at}temple.edu.
Thrombin has been known to cause tyrosine phosphorylation of protein kinase (PKC) in platelets, but the molecular mechanisms and function of this tyrosine phosphorylation is not known. In this study, we investigated the signaling pathways utilized by protease-activated receptors (PAR) to cause tyrosine phosphorylation of PKC and the role of this event in platelet function. PKC was tyrosine phosphorylated by either PAR1 or PAR4 in a concentration- and time-dependent manner in human platelets. In particular, only the tyrosine 311 residue was phosphorylated downstream of PAR receptors. Also the tyrosine phosphorylation of PKC did not occur in G q-deficient mouse platelets and was inhibited in the presence of a phospholipase C (PLC) inhibitor, U73122 and calcium chelator BAPTA suggesting a role for G q pathways and calcium in this event. Both PAR1 and PAR4 caused a time-dependent activation of Src tyrosine kinase and Src tyrosine kinase inhibitors completely blocked the tyrosine phosphorylation of PKC . Inhibition of tyrosine phosphorylation or the kinase activity of PKC dramatically blocked PAR-mediated thromboxane A2 generation. We conclude that thrombin causes tyrosine phosphorylation of PKC in a calcium- and Src-family kinase dependent manner in platelets, with functional implications in thromboxane A2 generation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Chari, T. Getz, B. Nagy Jr, K. Bhavaraju, Y. Mao, Y. S. Bynagari, S. Murugappan, K. Nakayama, and S. P. Kunapuli
Protein Kinase C{delta} Differentially Regulates Platelet Functional Responses
Arterioscler Thromb Vasc Biol,
May 1, 2009;
29(5):
699 - 705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Nagy Jr, K. Bhavaraju, T. Getz, Y. S. Bynagari, S. Kim, and S. P. Kunapuli
Impaired activation of platelets lacking protein kinase C-{theta} isoform
Blood,
March 12, 2009;
113(11):
2557 - 2567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. A. Karim, W. Choi, and S. W. Whiteheart
Primary Platelet Signaling Cascades and Integrin-mediated Signaling Control ADP-ribosylation Factor (Arf) 6-GTP Levels during Platelet Activation and Aggregation
J. Biol. Chem.,
May 2, 2008;
283(18):
11995 - 12003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Valiyaveettil, N. Kar, M. Z. Ashraf, T. V. Byzova, M. Febbraio, and E. A. Podrez
Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI
Blood,
February 15, 2008;
111(4):
1962 - 1971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Cao, K. Yu, C. Banh, V. Nguyen, A. Ritz, B. J. Raphael, Y. Kawakami, T. Kawakami, and A. R. Salomon
Quantitative Time-Resolved Phosphoproteomic Analysis of Mast Cell Signaling
J. Immunol.,
November 1, 2007;
179(9):
5864 - 5876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. N. Kahner, R. T. Dorsam, S. R. Mada, S. Kim, T. J. Stalker, L. F. Brass, J. L. Daniel, D. Kitamura, and S. P. Kunapuli
Hematopoietic lineage cell specific protein 1 (HS1) is a functionally important signaling molecule in platelet activation
Blood,
October 1, 2007;
110(7):
2449 - 2456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Huang, L. Dong, T. Kozasa, and G. C. Le Breton
Signaling through G{alpha}13 Switch Region I Is Essential for Protease-activated Receptor 1-mediated Human Platelet Shape Change, Aggregation, and Secretion
J. Biol. Chem.,
April 6, 2007;
282(14):
10210 - 10222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Shankar, B. N. Kahner, J. Prabhakar, P. Lakhani, S. Kim, and S. P. Kunapuli
G-protein-gated inwardly rectifying potassium channels regulate ADP-induced cPLA2 activity in platelets through Src family kinases
Blood,
November 1, 2006;
108(9):
3027 - 3034.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Yacoub, J.-F. Theoret, L. Villeneuve, H. Abou-Saleh, W. Mourad, B. G. Allen, and Y. Merhi
Essential Role of Protein Kinase C{delta} in Platelet Signaling, {alpha}IIbbeta3 Activation, and Thromboxane A2 Release
J. Biol. Chem.,
October 6, 2006;
281(40):
30024 - 30035.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-Y. Wang, Y.-C. Wu, and C.-C. Wu
Prevention of Platelet Glycoprotein IIb/IIIa Activation by 3,4-Methylenedioxy-beta-Nitrostyrene, A Novel Tyrosine Kinase Inhibitor
Mol. Pharmacol.,
October 1, 2006;
70(4):
1380 - 1389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Holinstat, B. Voss, M. L. Bilodeau, J. N. McLaughlin, J. Cleator, and H. E. Hamm
PAR4, but Not PAR1, Signals Human Platelet Aggregation via Ca2+ Mobilization and Synergistic P2Y12 Receptor Activation
J. Biol. Chem.,
September 8, 2006;
281(36):
26665 - 26674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Mundell, M. L. Jones, A. R. Hardy, J. F. Barton, S. M. Beaucourt, P. B. Conley, and A. W. Poole
Distinct Roles for Protein Kinase C Isoforms in Regulating Platelet Purinergic Receptor Function
Mol. Pharmacol.,
September 1, 2006;
70(3):
1132 - 1142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Garcia, T. M. Quinton, R. T. Dorsam, and S. P. Kunapuli
Src family kinase-mediated and Erk-mediated thromboxane A2 generation are essential for VWF/GPIb-induced fibrinogen receptor activation in human platelets
Blood,
November 15, 2005;
106(10):
3410 - 3414.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|